Bryan Johnson· Author
as it is not proven that reversing epigenetic age clocks improves clinical outcomes, whereas reversing phenotypic markers do.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
as it is not proven that reversing epigenetic age clocks improves clinical outcomes, whereas reversing phenotypic markers do.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
ea is silver standard to gold standard phenotypic aging markers bc not proven that reversal improves clinical outcomes
Epigenetic based tests are currently silver standard to gold standard phenotypic aging markers